Removing the IPMK gene from intestinal cells in mice decreases HDAC3 activity, which leads to changes in gene expression that weaken the intestinal barrier.

We analyzed the available evidence and found that removing the IPMK gene from intestinal cells in mice is linked to reduced HDAC3 activity, which appears to alter gene expression in a way that weakens the intestinal barrier [1]. HDAC3 is a protein involved in controlling how genes are turned on or off, and in this case, its lower activity seems to affect the cells that line the gut. The intestinal barrier acts like a selective wall — it lets nutrients in while keeping harmful substances out. When it weakens, it may allow things it normally blocks to pass through. So far, all eight studies or assertions we reviewed point to this same pattern: deleting IPMK leads to less HDAC3 activity and a less effective barrier in mouse models. There are no studies in our review that contradict this. However, we want to be clear — this evidence comes only from mice, and we don’t yet know if the same thing happens in humans. We also don’t know how long these changes last or whether they lead to visible health effects like inflammation or digestive issues. The evidence we’ve reviewed so far leans toward the idea that IPMK plays a role in maintaining gut barrier strength through HDAC3, but we can’t say this is a direct cause-and-effect relationship in people. More research is needed to understand if this mechanism matters outside of lab settings. In everyday terms: if you’re trying to keep your gut healthy, this suggests that genes like IPMK might help your gut lining stay strong — but we don’t yet know how to influence this in real life. For now, focusing on proven habits like eating fiber, staying hydrated, and managing stress remains the most reliable approach.